Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Pakistan

Faisalabad clinics, Faisalabad, Punjab Province

Aap ka Clinic, Lahore, Punjab Province